These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence. Rahaghi FF, Miravitlles M. Respir Res; 2017 May 30; 18(1):105. PubMed ID: 28558837 [Abstract] [Full Text] [Related]
4. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency. Hubbard RC, Crystal RG. Am J Med; 1988 Jun 24; 84(6A):52-62. PubMed ID: 3289387 [Abstract] [Full Text] [Related]
5. Impact of a Health Management Program on Healthcare Outcomes among Patients on Augmentation Therapy for Alpha 1-Antitrypsin Deficiency: An Insurance Claims Analysis. Campos MA, Runken MC, Davis AM, Johnson MP, Stone GA, Buikema AR. Adv Ther; 2018 Apr 24; 35(4):467-481. PubMed ID: 29616482 [Abstract] [Full Text] [Related]
6. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Chapman KR, Burdon JG, Piitulainen E, Sandhaus RA, Seersholm N, Stocks JM, Stoel BC, Huang L, Yao Z, Edelman JM, McElvaney NG, RAPID Trial Study Group. Lancet; 2015 Jul 25; 386(9991):360-8. PubMed ID: 26026936 [Abstract] [Full Text] [Related]